Clinical study of Patoladi Kwath in Bronchial Asthma

Randomized controlled clinical study to evaluate the efficacy of Patoladi Kwath in Tamakshwasa with special reference to Bronchial Asthma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/039036

Enrollment

Registered

2021-12-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Diagnosed patients of Tamakshwasa in Avega-awastha. 2) Age: 20 to 70 Years. 3) Gender: Male & Female.

Exclusion criteria

Exclusion criteria: 1) Pregnant Woman 2) Status Asthmatics & Cardiac Asthma 3) Patient of Tamakshwasa with secondary infections. 4) Patient suffering from systemic disorders like Tuberculosis, Emphysema, Cor Pulmonale, Diabetes etc.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Patoladi Kwath with Tab Derriphylline in Tamakshwas.Timepoint: 2 Weeks	—

Secondary

Measure	Time frame
1) To compare the effect of Patoladi Kwath in Tamakshwasa on the basis of pulmonary function test. 2) To compare the effect of Patoladi Kwath in Tamakshwasa on the basis of Absolute Eosinophil Count.Timepoint: 14 days	—

Countries

India

Contacts

Public ContactDr Radhika B Ghumare

MAMs Sumatibhai Shah Ayurved College

radhikaghumare3042@gmail.com

Outcome results